A small device placed behind the ear targets the nervous system to help reduce pain and provide relief for kids with irritable bowel syndrome (IBS).

Zuranolone (Zurzuvae), the first pill for patients suffering from postpartum depression, is expected to be available by the end of 2023. Though it may relieve depressive symptoms, it has some drawbacks such as sedation and dangers in breastfeeding.

Vizient Inc. has named UCSF Health as a Top Performer for its high-quality patient care in the 2023 Bernard A. Birnbaum, MD, Quality Leadership Ranking.

UCSF students and postdocs join advocates from around the country for the 2023 Rally for Medical Research to call on our nation’s policymakers to make funding for NIH a national priority and raise awareness about the importance of continued investment in medical research.

UCSF Health achieves 150 robotic focal HIFU procedures for prostate cancer, pioneering precision therapy with minimal side effects, prioritizing quality of life preservation.

Laura Persson, PhD, wins the 2023 Postdoc Slam with her talk titled “The Wormnado: What a tiny worm can teach us about collective behavior.”

UCSF has been given the green light on a new research and academic building at Parnassus Heights, creating a vital collaborative space to drive innovations in scientific research and education.

Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.